Martin McGlynn

2016

In 2016, Martin McGlynn earned a total compensation of $1.5M as Former Chief Executive Officer at StemCells, a 40% decrease compared to previous year.

Compensation breakdown

Salary$952,396
Other$570,000
Total$1,522,396

McGlynn received $952.4K in salary, accounting for 63% of the total pay in 2016.

McGlynn also received $570K in other compensation.

Rankings

In 2016, Martin McGlynn's compensation ranked 6,189th out of 14,075 executives tracked by ExecPay. In other words, McGlynn earned more than 56.0% of executives.

ClassificationRankingPercentile
All
6,189
out of 14,075
56th
Division
Manufacturing
2,271
out of 5,489
59th
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
303
out of 827
63rd
Industry group
Surgical, Medical, And Dental Instruments And Supplies
162
out of 510
68th
Industry
Surgical and Medical Instruments and Apparatus
88
out of 313
72nd
Source: SEC filing on August 11, 2017.

McGlynn's colleagues

We found seven more compensation records of executives who worked with Martin McGlynn at StemCells in 2016.

2016

Kenneth Stratton

StemCells

General Counsel

2016

George Koshy

StemCells

Chief Accounting Officer

2016

Gregory Schiffman

StemCells

Chief Financial Officer

2016

Ian Massey

StemCells

Chief Executive Officer

2016

Harel Gadot

StemCells

Chief Executive Officer

2016

Hezi Himelfarb

StemCells

Chief Operating Officer

2016

David Naim

StemCells

Chief Financial Officer

You may also like